156 related articles for article (PubMed ID: 35811413)
1. Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review.
Antoñanzas J; Rodríguez-Garijo N; Estenaga Á; Morelló-Vicente A; España A; Aguado L
Dermatol Ther; 2022 Sep; 35(9):e15709. PubMed ID: 35811413
[TBL] [Abstract][Full Text] [Related]
2. Deep morphea after vaccination in two young children.
Torrelo A; Suárez J; Colmenero I; Azorín D; Perera A; Zambrano A
Pediatr Dermatol; 2006; 23(5):484-7. PubMed ID: 17014648
[TBL] [Abstract][Full Text] [Related]
3. SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study.
Luchetti Gentiloni MM; Paci V; Marconi V; Gigli M; Benfaremo D; Sordillo R; Macchini C; Massaccesi L; Perna GP; Offidani AM; Moroncini G
Front Immunol; 2022; 13():859550. PubMed ID: 35386714
[TBL] [Abstract][Full Text] [Related]
4. Generalized morphea after COVID-19 vaccines: a case series.
Paolino G; Campochiaro C; Di Nicola MR; Mercuri SR; Rizzo N; Dagna L; Rongioletti F; De Luca G
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e680-e682. PubMed ID: 35604052
[No Abstract] [Full Text] [Related]
5. SARS-CoV-2 vaccination-induced cutaneous vasculitis: Report of two new cases and literature review.
Abdelmaksoud A; Wollina U; Temiz SA; Hasan A
Dermatol Ther; 2022 Jun; 35(6):e15458. PubMed ID: 35306713
[TBL] [Abstract][Full Text] [Related]
6. An impressive case of alopecia universalis after COVID-19 vaccination: a coincidental finding or a consequence?
Peterle L; Macca L; Li Pomi F; Vaccaro F; Borgia F; Vaccaro M
Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):437-441. PubMed ID: 36647894
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature.
Ramdas S; Hum RM; Price A; Paul A; Bland J; Burke G; Farrugia M; Palace J; Storrie A; Ho P; Standing E; Lilleker JB; Jungbluth H
Neuromuscul Disord; 2022 Oct; 32(10):785-789. PubMed ID: 36130855
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
9. A Case of Morphea After COVID-19 Vaccination.
Sharma A; Sandhu A
Dermatitis; 2024; 35(2):187-188. PubMed ID: 37610869
[No Abstract] [Full Text] [Related]
10. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
Choi YY; Kim MK; Kwon HC; Kim GH
J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
[TBL] [Abstract][Full Text] [Related]
11. A case of morphea following the COVID-19 mRNA vaccine: on the basis of viral spike proteins.
Metin Z; Celepli P
Int J Dermatol; 2022 May; 61(5):639-641. PubMed ID: 35073411
[No Abstract] [Full Text] [Related]
12. Herpes zoster following vaccination with ChAdOx1 nCoV-19 Coronavirus vaccine (recombinant).
Job AM; Sudhamani B; Mohan M; Mohanasundaram SN
Indian J Public Health; 2022; 66(1):83-85. PubMed ID: 35381724
[TBL] [Abstract][Full Text] [Related]
13. Morphea and COVID-19 mRNA vaccine.
Sookaromdee P; Wiwanitkit V
Int J Dermatol; 2022 May; 61(5):e162. PubMed ID: 35230704
[No Abstract] [Full Text] [Related]
14. Thyrotoxicosis following SARS-COV-2 vaccination: a case series and discussion.
Pla Peris B; Merchante Alfaro AÁ; Maravall Royo FJ; Abellán Galiana P; Pérez Naranjo S; González Boillos M
J Endocrinol Invest; 2022 May; 45(5):1071-1077. PubMed ID: 35015288
[TBL] [Abstract][Full Text] [Related]
15. Generalized morphea induced by the COVID-19 vaccine in a patient with chronic urticaria.
Alotaibi H; Alsalhi A; Albinhar T; Alshathry Y; Barakeh M
Dermatol Reports; 2023 Jun; 15(2):9632. PubMed ID: 37397404
[TBL] [Abstract][Full Text] [Related]
16. Generalized erythrodermic psoriasis triggered by vaccination against severe acute respiratory syndrome Coronavirus 2.
Tran TB; Pham NTU; Phan HN; Nguyen HT
Dermatol Ther; 2022 Jun; 35(6):e15464. PubMed ID: 35306720
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
[TBL] [Abstract][Full Text] [Related]
18. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
Weaver KN; Zhang X; Dai X; Watkins R; Adler J; Dubinsky MC; Kastl A; Bousvaros A; Strople JA; Cross RK; Higgins PDR; Ungaro RC; Bewtra M; Bellaguarda E; Farraye FA; Boccieri ME; Firestine A; Kappelman MD; Long MD
Inflamm Bowel Dis; 2022 Oct; 28(10):1497-1505. PubMed ID: 34871388
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 vaccine-related neurological complications.
Oonk NGM; Ettema AR; van Berghem H; de Klerk JJ; van der Vegt JPM; van der Meulen M
Neurol Sci; 2022 Apr; 43(4):2295-2297. PubMed ID: 35050428
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy.
Ameratunga R
Expert Rev Vaccines; 2022 Sep; 21(9):1177-1184. PubMed ID: 35695410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
